Switzerland Biotechnology & Medical Research

Newron Pharmaceuticals SpA (NWRN)

Track

Ticker: NWRN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Newron Pharmaceuticals SpA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 12 Aug 2026
Value CHF702,477.25 | Price 111.09 | Shares 22,417
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-12 B Purchase Executive Director / Officer
22,417
111.09
CHF702,477 		22,417 111.09 CHF702,477
2026-08-11 2026-08-11 B Purchase Executive Director / Officer
50,639
101.95
CHF1,685,067 		50,639 101.95 CHF1,685,067
2025-12-02 2025-12-02 S Sale Non-Executive Director
3,232
352.41
CHF4,212,523 		3,232 352.41 CHF4,212,523
2025-11-26 2025-11-26 S Sale Non-Executive Director
14,567
17.02
CHF247,984 		14,567 17.02 CHF247,984
2025-04-23 2025-04-23 B Purchase Non-Executive Director
750
7.30
CHF5,472 		750 7.30 CHF5,472
2025-04-07 2025-04-07 B Purchase
3.1
Weber, Stefan
Management Board Member
5,000
6.90
€34,503 		5,000 6.90 €34,503
2025-04-07 2025-04-07 B Purchase Executive Director / Officer
5,000
6.47
CHF32,326 		5,000 6.47 CHF32,326
2024-06-27 2024-06-27 B Purchase Executive Director / Officer
2,500
8.42
CHF21,058 		2,500 8.42 CHF21,058
2024-06-25 2024-06-25 B Purchase Non-Executive Director
2,502
9.78
CHF24,471 		2,502 9.78 CHF24,471
2024-06-17 2024-06-17 B Purchase Non-Executive Director
5,498
9.76
CHF53,666 		5,498 9.76 CHF53,666
2024-06-14 2024-06-14 B Purchase Non-Executive Director
2,000
10.22
CHF20,440 		2,000 10.22 CHF20,440
2024-05-16 2024-05-16 S Sale Non-Executive Director
10,382
10.47
CHF108,677 		10,382 10.47 CHF108,677
2023-03-28 2023-03-28 B Purchase Non-Executive Director
7,000
5.98
CHF41,860 		7,000 5.98 CHF41,860
2022-05-09 2022-05-09 B Purchase Executive Director / Officer
9,832
1.45
CHF14,255 		9,832 1.45 CHF14,255
2020-11-19 2020-11-19 B Purchase Executive Director / Officer
10,000
2.00
CHF20,000 		10,000 2.00 CHF20,000
2020-06-02 2020-06-02 B Purchase Executive Director / Officer
10,000
1.86
CHF18,577 		10,000 1.86 CHF18,577
2020-05-06 2020-05-06 B Purchase Non-Executive Director
5,000
1.89
CHF9,460 		5,000 1.89 CHF9,460
2020-05-04 2020-05-04 B Purchase Executive Director / Officer
5,000
2.23
CHF11,150 		5,000 2.23 CHF11,150
2018-12-03 2018-12-03 B Purchase Executive Director / Officer
2,000
7.67
CHF15,342 		2,000 7.67 CHF15,342
2018-12-03 2018-12-03 B Purchase Non-Executive Director
3,000
7.70
CHF23,100 		3,000 7.70 CHF23,100
Explore more

More insider trading research around Newron Pharmaceuticals SpA

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index